tiprankstipranks
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF)
:BJTRF
US Market

Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Financial Statements

Compare
5 Followers

Beijing Tong Ren Tang Chinese Medicine Co Financial Overview

Beijing Tong Ren Tang Chinese Medicine Co's market cap is currently $865.83M. The company's EPS TTM is $0.075; its P/E ratio is 8.59; and it has a dividend yield of 6.51%. Beijing Tong Ren Tang Chinese Medicine Co is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueHK$ 1.52BHK$ 1.73BHK$ 1.56BHK$ 1.32BHK$ 1.43B
Gross ProfitHK$ 1.05BHK$ 1.15BHK$ 1.12BHK$ 952.90MHK$ 1.01B
Operating IncomeHK$ 624.15MHK$ 811.58MHK$ 778.46MHK$ 669.40MHK$ 651.99M
EBITDAHK$ 779.54MHK$ 907.63MHK$ 852.81MHK$ 769.14MHK$ 774.64M
Net IncomeHK$ 540.39MHK$ 645.88MHK$ 607.84MHK$ 542.46MHK$ 556.12M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 2.38BHK$ 2.24BHK$ 2.28BHK$ 1.85BHK$ 1.97B
Total AssetsHK$ 4.43BHK$ 4.23BHK$ 3.83BHK$ 3.42BHK$ 3.14B
Total DebtHK$ 131.81MHK$ 103.08MHK$ 128.48MHK$ 106.01MHK$ 99.88M
Net DebtHK$ -868.00MHK$ -1.89BHK$ -1.53BHK$ -1.32BHK$ -956.84M
Total LiabilitiesHK$ 413.75MHK$ 486.49MHK$ 295.48MHK$ 287.46MHK$ 372.69M
Stockholders' EquityHK$ 3.87BHK$ 3.60BHK$ 3.42BHK$ 3.02BHK$ 2.66B
Cash Flow
Free Cash FlowHK$ 438.96MHK$ 508.94MHK$ 753.74MHK$ 103.17MHK$ 534.02M
Operating Cash FlowHK$ 460.83MHK$ 547.44MHK$ 777.17MHK$ 116.05MHK$ 551.01M
Investing Cash FlowHK$ -1.08BHK$ 335.41MHK$ -265.73MHK$ 506.73MHK$ 835.54M
Financing Cash FlowHK$ -372.18MHK$ -535.42MHK$ -278.65MHK$ -264.30MHK$ -878.67M
Currency in HKD

Beijing Tong Ren Tang Chinese Medicine Co Earnings and Revenue History

Beijing Tong Ren Tang Chinese Medicine Co Debt to Assets

Beijing Tong Ren Tang Chinese Medicine Co Cash Flow

Beijing Tong Ren Tang Chinese Medicine Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis